Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroectodermal Tumors, Primitive × ribociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Glioma 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Diffuse Intrinsic Pontine Glioma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteitis Deformans 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms, Male 1

Interventions

antineoplaston AS 2-1 3 antineoplaston A10 3 dactolisib 2 Temozolomide 2 Irinotecan 2 Everolimus 2 Bevacizumab 2 spartalizumab 1 poly ICLC 1 plerixafor 1 pasireotide 1 fosbretabulin 1 cixutumumab 1 adavosertib 1 Vaccines 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 PM 00104 1 Lapatinib 1 Immunologic Techniques 1 Immunoglobulin G 1 Genistein 1 Fentanyl 1 Donepezil 1 Disulfides 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡